E.B.Enviro Biotech Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 06-07-2024
- Paid Up Capital ₹ 1.50 M
as on 06-07-2024
- Company Age 19 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 4.00 M
as on 06-07-2024
- Revenue -11.84%
(FY 2020)
- Profit -50.57%
(FY 2020)
- Ebitda 22.87%
(FY 2020)
- Net Worth 4.00%
(FY 2020)
- Total Assets 34.96%
(FY 2020)
About E.B.Enviro Biotech
The Company is engaged in the Environment Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.50 M.
The company currently has active open charges totaling ₹4.00 M.
Sunil Pawar, Shraddha Pawar, Suwarna Pawar, and One other member serve as directors at the Company.
- CIN/LLPIN
U24120MH2005PTC154938
- Company No.
154938
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Jul 2005
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Nashik, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at E.B.Enviro Biotech?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sunil Pawar  | Director | 20-Jul-2005 | Current |
| Suwarna Pawar | Director | 01-Dec-2015 | Current |
| Shraddha Pawar | Director | 20-Jul-2005 | Current |
| Siddhant Pawar | Director | 01-Apr-2021 | Current |
Financial Performance and Corporate Structure Insights of E.B.Enviro Biotech.
E.B.Enviro Biotech Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 11.84% decrease. The company also saw a substantial fall in profitability, with a 50.57% decrease in profit. The company's net worth moved up by a moderate rise of 4%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of E.B.Enviro Biotech?
In 2020, E.B.Enviro Biotech had a promoter holding of 100.00%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Siddhi Biomanagement Private LimitedActive 19 years 13 daysSunil Pawar and Siddhant Pawar are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 04 Feb 2010 | ₹4.00 M | Open |
How Many Employees Work at E.B.Enviro Biotech?
E.B.Enviro Biotech has a workforce of 2 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of E.B.Enviro Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped E.B.Enviro Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
